These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12499392)

  • 1. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration.
    Klerkx AH; Tanck MW; Kastelein JJ; Molhuizen HO; Jukema JW; Zwinderman AH; Kuivenhoven JA
    Hum Mol Genet; 2003 Jan; 12(2):111-23. PubMed ID: 12499392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
    Eiriksdottir G; Bolla MK; Thorsson B; Sigurdsson G; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Nov; 159(1):187-92. PubMed ID: 11689220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group.
    Gudnason V; Kakko S; Nicaud V; Savolainen MJ; Kesäniemi YA; Tahvanainen E; Humphries S
    Eur J Clin Invest; 1999 Feb; 29(2):116-28. PubMed ID: 10092998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and plasma lipoprotein levels in familial hypercholesterolemia.
    Carmena-Ramón R; Ascaso JF; Real JT; Nájera G; Ordovás JM; Carmena R
    Metabolism; 2001 Jun; 50(6):651-6. PubMed ID: 11398140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness.
    Kakko S; Tamminen M; Päivänsalo M; Kauma H; Rantala AO; Lilja M; Reunanen A; Kesäniemi YA; Savolainen MJ
    Eur J Clin Invest; 2001 Jul; 31(7):593-602. PubMed ID: 11454014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CETP gene variation: relation to lipid parameters and cardiovascular risk.
    Boekholdt SM; Kuivenhoven JA; Hovingh GK; Jukema JW; Kastelein JJ; van Tol A
    Curr Opin Lipidol; 2004 Aug; 15(4):393-8. PubMed ID: 15243211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TaqIB and -629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey.
    Tai ES; Ordovas JM; Corella D; Deurenberg-Yap M; Chan E; Adiconis X; Chew SK; Loh LM; Tan CE
    Clin Genet; 2003 Jan; 63(1):19-30. PubMed ID: 12519368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk.
    Papp AC; Pinsonneault JK; Wang D; Newman LC; Gong Y; Johnson JA; Pepine CJ; Kumari M; Hingorani AD; Talmud PJ; Shah S; Humphries SE; Sadee W
    PLoS One; 2012; 7(3):e31930. PubMed ID: 22403620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
    Klerkx AH; de Grooth GJ; Zwinderman AH; Jukema JW; Kuivenhoven JA; Kastelein JJ
    Eur J Clin Invest; 2004 Jan; 34(1):21-8. PubMed ID: 14984434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.
    Corella D; Sáiz C; Guillén M; Portolés O; Mulet F; González JI; Ordovás JM
    Atherosclerosis; 2000 Oct; 152(2):367-76. PubMed ID: 10998464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.